448 lines
30 KiB
HTML
448 lines
30 KiB
HTML
<!DOCTYPE html>
|
||
<html lang="zh-CN" data-theme="night">
|
||
<head>
|
||
<meta charset="UTF-8">
|
||
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
||
<title>AI 医疗 | 深度行业研究</title>
|
||
|
||
<!-- Tailwind CSS & DaisyUI -->
|
||
<link href="https://cdn.jsdelivr.net/npm/daisyui@4.11.1/dist/full.min.css" rel="stylesheet" type="text/css" />
|
||
<script src="https://cdn.tailwindcss.com"></script>
|
||
|
||
<!-- Alpine.js -->
|
||
<script defer src="https://cdn.jsdelivr.net/npm/alpinejs@3.x.x/dist/cdn.min.js"></script>
|
||
|
||
<!-- ECharts -->
|
||
<script src="https://cdn.jsdelivr.net/npm/echarts@5.5.0/dist/echarts.min.js"></script>
|
||
|
||
<!-- Google Fonts -->
|
||
<link rel="preconnect" href="https://fonts.googleapis.com">
|
||
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
|
||
<link href="https://fonts.googleapis.com/css2?family=Lexend:wght@300;400;500;600&family=IBM+Plex+Mono:wght@400;500;700&display=swap" rel="stylesheet">
|
||
|
||
<style>
|
||
:root {
|
||
--glow-color: rgba(79, 70, 229, 0.6);
|
||
--glow-color-light: rgba(129, 140, 248, 0.7);
|
||
}
|
||
|
||
body {
|
||
font-family: 'Lexend', sans-serif;
|
||
background-color: #020010;
|
||
background-image:
|
||
radial-gradient(at 20% 20%, hsla(212, 80%, 30%, 0.3) 0px, transparent 50%),
|
||
radial-gradient(at 80% 20%, hsla(289, 70%, 40%, 0.25) 0px, transparent 50%),
|
||
radial-gradient(at 50% 80%, hsla(190, 80%, 50%, 0.2) 0px, transparent 50%);
|
||
color: #e0e0e0;
|
||
}
|
||
|
||
.glass-card {
|
||
background: rgba(16, 17, 34, 0.4);
|
||
backdrop-filter: blur(12px) saturate(150%);
|
||
-webkit-backdrop-filter: blur(12px) saturate(150%);
|
||
border: 1px solid rgba(255, 255, 255, 0.1);
|
||
border-radius: 1.5rem; /* 24px */
|
||
transition: all 0.3s ease;
|
||
}
|
||
.glass-card:hover {
|
||
box-shadow: 0 0 25px 0 rgba(79, 70, 229, 0.2);
|
||
border-color: rgba(79, 70, 229, 0.3);
|
||
}
|
||
|
||
.glow-text {
|
||
text-shadow: 0 0 8px var(--glow-color-light), 0 0 12px var(--glow-color);
|
||
}
|
||
|
||
.section-title {
|
||
font-family: 'IBM Plex Mono', monospace;
|
||
text-transform: uppercase;
|
||
letter-spacing: 0.1em;
|
||
}
|
||
|
||
.timeline {
|
||
position: relative;
|
||
padding: 2rem 0;
|
||
}
|
||
.timeline::before {
|
||
content: '';
|
||
position: absolute;
|
||
top: 0;
|
||
left: 20px;
|
||
height: 100%;
|
||
width: 2px;
|
||
background: linear-gradient(to bottom, rgba(79, 70, 229, 0), var(--glow-color), rgba(79, 70, 229, 0));
|
||
}
|
||
.timeline-item {
|
||
position: relative;
|
||
padding-left: 50px;
|
||
margin-bottom: 2rem;
|
||
}
|
||
.timeline-item::before {
|
||
content: '';
|
||
position: absolute;
|
||
left: 12px;
|
||
top: 5px;
|
||
width: 16px;
|
||
height: 16px;
|
||
border-radius: 50%;
|
||
background-color: var(--glow-color-light);
|
||
border: 3px solid #020010;
|
||
box-shadow: 0 0 10px var(--glow-color-light);
|
||
}
|
||
</style>
|
||
</head>
|
||
|
||
<body class="min-h-screen p-4 sm:p-6 lg:p-8">
|
||
<div class="max-w-7xl mx-auto space-y-12">
|
||
|
||
<!-- Header -->
|
||
<header class="text-center py-8">
|
||
<h1 class="text-4xl md:text-6xl font-bold glow-text bg-clip-text text-transparent bg-gradient-to-br from-white to-indigo-300">
|
||
AI 医疗
|
||
</h1>
|
||
<p class="mt-4 text-xl md:text-2xl text-indigo-200 section-title tracking-widest">深度行业研究</p>
|
||
<p class="mt-4 text-sm text-gray-400">
|
||
北京价值前沿科技有限公司 AI投研agent：“价小前投研” 呈现
|
||
</p>
|
||
</header>
|
||
|
||
<!-- Bento Grid: Overview -->
|
||
<section class="grid grid-cols-1 lg:grid-cols-3 gap-6">
|
||
<div class="lg:col-span-2 glass-card p-6 flex flex-col justify-center">
|
||
<h2 class="section-title text-xl text-indigo-300 mb-4">核心观点摘要</h2>
|
||
<p class="text-gray-300 leading-relaxed">
|
||
AI医疗正处在一个由“技术平权”引爆的<strong class="text-white font-semibold">商业化落地加速期</strong>。其核心驱动力已从单纯的技术探索，转变为“<strong class="text-indigo-300">政策强力催化 + 数据价值重估 + 明确降本增效需求</strong>”三轮驱动的新阶段。未来，赛道的潜力将取决于能否构建“数据-模型-场景”的商业闭环，而短期内，拥有高质量专有数据和清晰应用场景的公司将率先兑现价值。
|
||
</p>
|
||
</div>
|
||
<div class="glass-card p-6">
|
||
<h2 class="section-title text-lg text-indigo-300 mb-2 text-center">市场规模 (国内)</h2>
|
||
<div id="marketSizeChart" class="w-full h-64"></div>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Timeline: Concept Events -->
|
||
<section class="glass-card p-8">
|
||
<h2 class="section-title text-2xl text-indigo-300 mb-8">概念发展脉络</h2>
|
||
<div class="timeline">
|
||
<div class="timeline-item">
|
||
<h3 class="font-bold text-lg text-white">技术奠基与范式变革期 <span class="text-sm font-normal text-gray-400 ml-2">(2024年初 - 2025年Q1)</span></h3>
|
||
<p class="text-gray-300 mt-2">以 <strong class="text-indigo-300">DeepSeek 开源低成本大模型</strong>为标志性事件，极大降低AI部署门槛，实现“AI平权”。产业焦点从模型能力转向数据价值开发与应用场景落地，<strong class="font-semibold text-white">AI医疗订单与项目自25Q1起加速落地</strong>。</p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-bold text-lg text-white">政策密集催化与生态构建期 <span class="text-sm font-normal text-gray-400 ml-2">(2025年Q2 - 至今)</span></h3>
|
||
<p class="text-gray-300 mt-2">国家层面印发<strong class="text-indigo-300">《医药工业数智化转型实施方案》</strong>，地方（广东）发布应用场景案例。华为组建医疗军团、支付宝推出医疗Agent，产业巨头入局，生态构建加速。</p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-bold text-lg text-white">市场验证与海外映射期 <span class="text-sm font-normal text-gray-400 ml-2">(2025年中)</span></h3>
|
||
<p class="text-gray-300 mt-2">英伟达<strong class="text-indigo-300">H20芯片恢复对华销售</strong>，解决硬件端瓶颈。美股AI医疗龙头 <strong class="font-semibold text-white">Tempus AI (Q1收入+75.4%)</strong> 等股价持续上涨，为A股提供了AI赋能医疗数据价值重估的清晰映射逻辑。</p>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Core Logic & Analysis -->
|
||
<section class="glass-card p-8" x-data="{ tab: 'drivers' }">
|
||
<div class="tabs tabs-boxed bg-black/20 mb-6">
|
||
<a class="tab tab-lg" :class="{ 'tab-active': tab === 'drivers' }" @click.prevent="tab = 'drivers'">核心驱动力</a>
|
||
<a class="tab tab-lg" :class="{ 'tab-active': tab === 'expectation' }" @click.prevent="tab = 'expectation'">市场预期差</a>
|
||
<a class="tab tab-lg" :class="{ 'tab-active': tab === 'path' }" @click.prevent="tab = 'path'">未来发展路径</a>
|
||
</div>
|
||
|
||
<div x-show="tab === 'drivers'" class="space-y-6">
|
||
<h3 class="section-title text-2xl text-indigo-300">核心驱动力分析</h3>
|
||
<div class="grid md:grid-cols-2 gap-6">
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-white text-lg">1. 技术范式转变 (AI平权)</h4>
|
||
<p class="text-gray-400 mt-2">以DeepSeek为代表的低成本、高性能开源大模型，使AI部署进入“零门槛”时代，解决了医疗IT企业“有数据、无能力”的困境，竞争核心回归到行业数据本身的质量、维度和稀缺性。</p>
|
||
</div>
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-white text-lg">2. 政策顶层设计与强力推动</h4>
|
||
<p class="text-gray-400 mt-2">从工信部《转型方案》到广东省《场景案例》，政策不仅是口号，更给出了具体实施路径和应用场景，为商业化提供了确定性，降低了医院等下游客户的采纳顾虑。</p>
|
||
</div>
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-white text-lg">3. 数据价值的根本性重估</h4>
|
||
<p class="text-gray-400 mt-2">“本轮AI应用商业化落地本质在于行业数据”。联影医疗、Tempus AI等案例印证了高质量、多模态的专有数据是构筑竞争壁垒的核心。AI技术激活了沉睡的数据资产。</p>
|
||
</div>
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-white text-lg">4. 明确的商业化需求 (降本增效)</h4>
|
||
<p class="text-gray-400 mt-2">当前医院采购AI的核心动力是效率提升，而非依赖医保。例如联影的“一扫多查”、讯飞的“智医助理”，旨在解决医疗资源不均、医生负荷大的现实痛点，商业逻辑清晰。</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div x-show="tab === 'expectation'" class="space-y-4">
|
||
<h3 class="section-title text-2xl text-indigo-300">市场预期差分析</h3>
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-white text-lg">盈利能力的预期差</h4>
|
||
<p class="text-gray-400 mt-2">市场可能因“订单加速”而对短期盈利过于乐观。但行业龙头（如联影智能2023年净亏损1.36亿元）仍处投入期，从订单到利润的转化难度和周期可能被低估。</p>
|
||
</div>
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-white text-lg">竞争格局的预期差</h4>
|
||
<p class="text-gray-400 mt-2">市场可能认为科技巨头将主导一切。但数据反复强调，掌握核心行业数据和场景的传统医疗IT/设备商转型AI更具优势。AI平权后，优势将从模型能力转向数据治理、场景理解和客户渠道。</p>
|
||
</div>
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-white text-lg">商业模式的预期差</h4>
|
||
<p class="text-gray-400 mt-2">市场可能仍在等待医保支付。但当前主流商业模式是面向B端的效率提升付费，以及面向药企的数据服务付费（如Tempus AI客户净留存率高达140%）。这些不依赖医保的模式可能比预期更快成熟。</p>
|
||
</div>
|
||
</div>
|
||
|
||
<div x-show="tab === 'path'" class="space-y-4">
|
||
<h3 class="section-title text-2xl text-indigo-300">长期发展路径</h3>
|
||
<ul class="steps steps-vertical">
|
||
<li class="step step-primary" data-content="1">
|
||
<div class="text-left ml-4">
|
||
<h4 class="font-semibold text-white text-lg">第一阶段 (当前-2027年) - “工具化”与“流程优化”</h4>
|
||
<p class="text-gray-400">以AI医学影像、CDSS等单点功能应用为主，商业模式以B端项目制、订阅费为主。关键里程碑是实现基层诊疗智能辅助应用基本覆盖。</p>
|
||
</div>
|
||
</li>
|
||
<li class="step step-primary" data-content="2">
|
||
<div class="text-left ml-4">
|
||
<h4 class="font-semibold text-white text-lg">第二阶段 (2027-2030年) - “平台化”与“多模态融合”</h4>
|
||
<p class="text-gray-400">AI Agent和多模态大模型成为主流，融合影像、基因、病理等多维数据，提供全流程解决方案。AI+慢病管理、AI+药物研发进入快速发展期。</p>
|
||
</div>
|
||
</li>
|
||
<li class="step" data-content="3">
|
||
<div class="text-left ml-4">
|
||
<h4 class="font-semibold text-white text-lg">第三阶段 (2030年以后) - “智能化”与“生态闭环”</h4>
|
||
<p class="text-gray-400">AI深度融入医疗体系，实现个性化精准医疗、AI自主研发新药。与硬件深度结合，形成“AI+医+药+险+康养”的生态闭环。</p>
|
||
</div>
|
||
</li>
|
||
</ul>
|
||
</div>
|
||
|
||
</section>
|
||
|
||
<!-- Industry Chain & Core Companies -->
|
||
<section class="glass-card p-8">
|
||
<h2 class="section-title text-2xl text-indigo-300 mb-8">产业链与核心玩家深度剖析</h2>
|
||
<div class="space-y-8">
|
||
<!-- Industry Chain Map -->
|
||
<div>
|
||
<h3 class="font-bold text-xl text-white mb-4">产业链图谱</h3>
|
||
<div class="grid grid-cols-1 md:grid-cols-3 gap-4 text-center">
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-indigo-300">上游 | 基础层</h4>
|
||
<p class="text-sm text-gray-300 mt-2">数据提供 (医院, 体检机构)<br>算力提供 (英伟达)<br>算法/模型 (DeepSeek, 华为盘古)</p>
|
||
</div>
|
||
<div class="p-4 bg-indigo-900/30 rounded-xl border border-indigo-500/50">
|
||
<h4 class="font-semibold text-indigo-200">中游 | 技术/应用层 <span class="badge badge-primary badge-sm ml-1">核心</span></h4>
|
||
<p class="text-sm text-gray-300 mt-2">AI+诊断 (联影, 讯飞)<br>AI+医疗IT (卫宁, 东软)<br>AI+药物研发 (泓博医药)</p>
|
||
</div>
|
||
<div class="p-4 bg-black/20 rounded-xl border border-white/10">
|
||
<h4 class="font-semibold text-indigo-300">下游 | 场景/用户层</h4>
|
||
<p class="text-sm text-gray-300 mt-2">G端 (卫健委, 医保局)<br>B端 (医院, 药企)<br>C端 (个人用户)</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- Core Players -->
|
||
<div>
|
||
<h3 class="font-bold text-xl text-white mb-4">核心玩家对比</h3>
|
||
<div class="space-y-4">
|
||
<div class="collapse collapse-plus glass-card">
|
||
<input type="radio" name="my-accordion-3" checked="checked" />
|
||
<div class="collapse-title text-xl font-medium text-white">
|
||
领导者梯队
|
||
</div>
|
||
<div class="collapse-content">
|
||
<p><strong>联影医疗:</strong> AI影像绝对龙头。“高端硬件+AI软件”生态闭环，拥有国内最多的12张三类证，监管与数据壁垒高。</p>
|
||
<p class="mt-2"><strong>讯飞医疗:</strong> 基层CDSS垄断者。基层市场61.5%占有率形成飞轮效应，背靠星火大模型，技术迭代快，G/B/C三端联动。</p>
|
||
</div>
|
||
</div>
|
||
<div class="collapse collapse-plus glass-card">
|
||
<input type="radio" name="my-accordion-3" />
|
||
<div class="collapse-title text-xl font-medium text-white">
|
||
核心追赶者/转型者
|
||
</div>
|
||
<div class="collapse-content">
|
||
<p><strong>卫宁健康/东软集团:</strong> 传统医疗IT巨头转型代表。优势在于庞大存量医院客户基础。东软集团Q1 AI订单+211%验证转型逻辑。</p>
|
||
<p class="mt-2"><strong>润达医疗:</strong> AI Agent潜力股。定位IVD数字化服务，与华为深度合作，Agent模式具备高成长性。</p>
|
||
</div>
|
||
</div>
|
||
<div class="collapse collapse-plus glass-card">
|
||
<input type="radio" name="my-accordion-3" />
|
||
<div class="collapse-title text-xl font-medium text-white">
|
||
数据价值核心标的
|
||
</div>
|
||
<div class="collapse-content">
|
||
<p><strong>医渡科技:</strong> 逻辑最纯粹的医疗数据处理与价值挖掘公司。核心优势是处理了50亿+医疗记录的“医疗大脑”，商业模式接近海外Tempus AI，潜力巨大。</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Investment Conclusion & Risks -->
|
||
<section class="grid grid-cols-1 lg:grid-cols-2 gap-6">
|
||
<div class="glass-card p-6">
|
||
<h2 class="section-title text-xl text-indigo-300 mb-4">综合结论与投资启示</h2>
|
||
<p class="text-gray-300 mb-4">AI医疗已进入由订单和应用驱动的<strong class="text-white">早期基本面兑现阶段</strong>。行业景气度向上，但距离大规模盈利仍有距离，属于典型的高成长、高估值、高风险赛道。投资逻辑应从“寻找概念”转向“甄选具备核心壁垒和落地能力的阿尔法”。</p>
|
||
<ul class="space-y-2 list-disc list-inside text-gray-300">
|
||
<li><strong class="text-indigo-300">短期 (1-2年):</strong> 关注强壁垒“AI+硬件/工具”提供商，如联影医疗、讯飞医疗。</li>
|
||
<li><strong class="text-indigo-300">中期 (2-3年):</strong> 关注订单强劲增长的“AI+IT”转型企业，如东软集团。</li>
|
||
<li><strong class="text-indigo-300">长期 (3-5年):</strong> 关注掌握高质量专有数据的平台型公司，如医渡科技。</li>
|
||
</ul>
|
||
</div>
|
||
<div class="glass-card p-6">
|
||
<h2 class="section-title text-xl text-red-400 mb-4">潜在风险与挑战</h2>
|
||
<ul class="space-y-3">
|
||
<li><strong class="text-red-300">技术风险:</strong> 大模型存在“幻觉”问题，在要求100%准确的医疗领域是致命短板。</li>
|
||
<li><strong class="text-red-300">商业化风险:</strong> 国内医院对纯软件付费意愿偏低；C端用户信任度、付费意愿是瓶颈。</li>
|
||
<li><strong class="text-red-300">政策与竞争风险:</strong> 数据安全与隐私监管日益严格；AI诊疗责任界定悬而未决；“AI平权”可能导致同质化竞争。</li>
|
||
<li><strong class="text-red-300">验证风险:</strong> 行业高速发展的新闻报道与部分公司财报亏损存在“温差”，需平衡看待景气度与个体盈利现实。</li>
|
||
</ul>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Stock Tables -->
|
||
<section class="space-y-12">
|
||
<div>
|
||
<h2 class="section-title text-2xl text-indigo-300 mb-6">相关标的梳理 | AI+诊断/检验/信息化</h2>
|
||
<div class="overflow-x-auto glass-card p-4">
|
||
<table class="table table-zebra w-full">
|
||
<thead class="text-indigo-300">
|
||
<tr>
|
||
<th>股票名称</th>
|
||
<th>核心逻辑/业务</th>
|
||
<th>细分赛道</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=603108" target="_blank" class="link link-hover">润达医疗 (603108)</a></td><td>第三方院内诊断机构排名第一、疾病智能诊疗、与华为合作良医小慧</td><td>AI+检验诊断</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=603882" target="_blank" class="link link-hover">金域医学 (603882)</a></td><td>智慧医检，接入DeepSeek大模型提升基因数据学习效率</td><td>AI+检验诊断</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=300244" target="_blank" class="link link-hover">迪安诊断 (300244)</a></td><td>细胞病理、组织病理AI辅助诊断，发布智慧实验室信息化管理系统</td><td>AI+检验诊断</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=002044" target="_blank" class="link link-hover">美年健康 (002044)</a></td><td>智能总检、与华为合作发布健康管理AI机器人“健康小美”</td><td>AI+病理诊断/健康管理</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=300676" target="_blank" class="link link-hover">华大基因 (300676)</a></td><td>发布首个基因检测多模态大模型GeneT，推出遗传病诊断智能化解读工具</td><td>AI诊断</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=600055" target="_blank" class="link link-hover">万东医疗 (600055)</a></td><td>AI影像技术，基于智慧天眼的MR、CT、DR等多产品线自动摆位技术</td><td>AI诊断</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=688358" target="_blank" class="link link-hover">祥生医疗 (688358)</a></td><td>超声AI产品“乳腺疾病超声辅助诊断软件”已取得Ⅲ类注册证</td><td>AI诊断</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=300253" target="_blank" class="link link-hover">卫宁健康 (300253)</a></td><td>国内医疗卫生信息化龙头，发布基于DS的WiNGPT2.8</td><td>AI+医疗数据信息</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=600718" target="_blank" class="link link-hover">东软集团 (600718)</a></td><td>全国医保平台主要承建商之一，25Q1新签AI+医疗合同同比+211%</td><td>AI+医疗数据信息</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=300451" target="_blank" class="link link-hover">创业慧康 (300451)</a></td><td>电子病历、医院智慧管理，25Q1新增多个含AI大模型部署的千万级订单</td><td>AI+医疗数据信息</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=300288" target="_blank" class="link link-hover">朗玛信息 (300288)</a></td><td>“39AI全科医生”大模型，应用于辅助诊断、健康咨询</td><td>AI+医疗数据信息</td></tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</div>
|
||
<div>
|
||
<h2 class="section-title text-2xl text-indigo-300 mb-6">相关标的梳理 | AI+制药/健康管理/自动化</h2>
|
||
<div class="overflow-x-auto glass-card p-4">
|
||
<table class="table table-zebra w-full">
|
||
<thead class="text-indigo-300">
|
||
<tr>
|
||
<th>股票名称</th>
|
||
<th>核心逻辑/业务</th>
|
||
<th>细分赛道</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=688222" target="_blank" class="link link-hover">成都先导 (688222)</a></td><td>推进DEL+AI在新药发现与优化方面的应用，AI模型基于海量真实实验数据</td><td>AI制药</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=301230" target="_blank" class="link link-hover">泓博医药 (301230)</a></td><td>设立CADD/AIDD技术平台，已累计为69个新药项目提供技术支持</td><td>AI制药</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=688131" target="_blank" class="link link-hover">皓元医药 (688131)</a></td><td>与多家AI制药公司形成战略合作，合作的合成预测平台可实现小分子合成路线预测</td><td>AI制药</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=002432" target="_blank" class="link link-hover">九安医疗 (002432)</a></td><td>投资月之暗面等AI公司，布局AI慢病医生助手</td><td>AI健康管理</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=300562" target="_blank" class="link link-hover">乐心医疗 (300562)</a></td><td>从消费级穿戴设备转向医疗级远程患者监测(RPM)服务，结合内测心血管大模型</td><td>AI健康管理</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=688329" target="_blank" class="link link-hover">艾隆科技 (688329)</a></td><td>智慧药房，自动化药房设备</td><td>AI+自动化药房</td></tr>
|
||
<tr><td><a href="https://valuefrontier.cn/company?scode=605186" target="_blank" class="link link-hover">健麾信息 (605186)</a></td><td>智慧药房、智能化静配中心、医保结算无人售药机</td><td>AI+自动化药房</td></tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Footer / Disclaimer -->
|
||
<footer class="text-center py-8 mt-12 border-t border-white/10">
|
||
<p class="text-sm text-gray-500">本报告由北京价值前沿科技有限公司 AI投研agent：“价小前投研” 合成生成。</p>
|
||
<p class="text-xs text-gray-600 mt-2">免责声明：本报告内容基于公开数据、新闻、路演、研报和insight分析，由AI模型处理和呈现，可能存在信息滞后或偏差。内容仅供研究参考，不构成任何投资建议。投资者据此操作，风险自担。投资有风险，入市需谨慎。</p>
|
||
</footer>
|
||
|
||
</div>
|
||
|
||
<script>
|
||
document.addEventListener('DOMContentLoaded', function () {
|
||
var chartDom = document.getElementById('marketSizeChart');
|
||
var myChart = echarts.init(chartDom);
|
||
var option;
|
||
|
||
option = {
|
||
backgroundColor: 'transparent',
|
||
tooltip: {
|
||
trigger: 'axis',
|
||
axisPointer: {
|
||
type: 'shadow'
|
||
},
|
||
backgroundColor: 'rgba(16, 17, 34, 0.7)',
|
||
borderColor: 'rgba(79, 70, 229, 0.5)',
|
||
textStyle: {
|
||
color: '#E0E0E0'
|
||
}
|
||
},
|
||
grid: {
|
||
left: '3%',
|
||
right: '4%',
|
||
bottom: '3%',
|
||
containLabel: true
|
||
},
|
||
xAxis: {
|
||
type: 'category',
|
||
data: ['2023年', '2024年 (预计)'],
|
||
axisLine: {
|
||
lineStyle: {
|
||
color: 'rgba(255, 255, 255, 0.3)'
|
||
}
|
||
},
|
||
axisLabel: {
|
||
color: '#A0AEC0'
|
||
}
|
||
},
|
||
yAxis: {
|
||
type: 'value',
|
||
name: '亿元',
|
||
axisLine: {
|
||
show: true,
|
||
lineStyle: {
|
||
color: 'rgba(255, 255, 255, 0.3)'
|
||
}
|
||
},
|
||
splitLine: {
|
||
lineStyle: {
|
||
color: 'rgba(255, 255, 255, 0.1)'
|
||
}
|
||
},
|
||
axisLabel: {
|
||
color: '#A0AEC0'
|
||
}
|
||
},
|
||
series: [{
|
||
name: '市场规模',
|
||
type: 'bar',
|
||
barWidth: '40%',
|
||
data: [780.5, 936.6],
|
||
itemStyle: {
|
||
color: new echarts.graphic.LinearGradient(0, 0, 0, 1, [
|
||
{ offset: 0, color: 'rgba(129, 140, 248, 0.8)' },
|
||
{ offset: 1, color: 'rgba(79, 70, 229, 0.8)' }
|
||
]),
|
||
borderRadius: [4, 4, 0, 0]
|
||
},
|
||
emphasis: {
|
||
itemStyle: {
|
||
color: new echarts.graphic.LinearGradient(0, 0, 0, 1, [
|
||
{ offset: 0, color: 'rgba(165, 180, 252, 1)' },
|
||
{ offset: 1, color: 'rgba(99, 102, 241, 1)' }
|
||
]),
|
||
}
|
||
},
|
||
label: {
|
||
show: true,
|
||
position: 'top',
|
||
color: '#FFFFFF',
|
||
formatter: '{c} 亿元'
|
||
}
|
||
}]
|
||
};
|
||
|
||
myChart.setOption(option);
|
||
window.addEventListener('resize', myChart.resize);
|
||
});
|
||
</script>
|
||
</body>
|
||
</html> |